Projects

Trials I run or help run, the register and biobank studies behind them, and the national pharmacogenetics work. Each card links to a short page with status, funding and collaborators.

SAMSON-2

Nationwide randomized trial testing a digital double-blind N-of-1 platform against standard care for statin intolerance. Sponsor and principal investigator.

National pharmacogenetics pipeline

One national method for pharmacogenetic results from whole-genome sequencing, from the National Genome Center to the prescriber. Initiative 2.1 of the National Strategy for…

TDM-VISION

Therapeutic drug monitoring of ibrutinib and venetoclax in chronic lymphocytic leukemia. Principal investigator, funded by the Danish Cancer Society.

Biobank pharmacogenetics

CYP2C19 and SLCO1B1 genotypes from the Copenhagen Hospital Biobank linked to antiplatelet and statin outcomes in nationwide registers.

SPOCK and European PGx networks

European clopidogrel pharmacogenomics consortium and working group participation in COST Action CardioPharmGeneNet and CPIC guideline development.